6446 — PHARMAESSENTIA Income Statement
0.000.00%
Last trade - 00:00- TWD102.56bn
- TWD84.07bn
- TWD5.11bn
Annual income statement for PHARMAESSENTIA, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 306 | 557 | 657 | 2,882 | 5,106 |
| Cost of Revenue | |||||
| Gross Profit | 244 | 184 | 278 | 2,070 | 4,495 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 1,155 | 2,251 | 3,464 | 4,910 | 7,019 |
| Operating Profit | -849 | -1,693 | -2,808 | -2,028 | -1,913 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -842 | -1,925 | -2,796 | -1,842 | -987 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -843 | -1,926 | -2,796 | -1,375 | -624 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | -843 | -1,926 | -2,796 | -1,375 | -624 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Dilution Adjustment | |||||
| Diluted Net Income | -843 | -1,926 | -2,796 | -1,375 | -624 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -3.71 | -7.88 | -10.6 | -4.84 | -1.93 |
| Dividends per Share |